Skip to main content
Premium Trial:

Request an Annual Quote

JCVI Researcher Awarded $5M Grant to Develop Wastewater Treatment Technology

NEW YORK (GenomeWeb News) – The J. Craig Venter Institute announced today that one of its researchers has received a $5 million grant from the Roddenberry Foundation to fund development of new wastewater treatment approaches based on microbial fuel cell, or MFC, technology.

MFCs are based on natural microbial communities that break down the organic material in sewage and other waste for fuel. According to JCVI, this process creates electrons that pass along the fuel cell circuitry to accelerate the breakdown process and produce electricity.

The JCVI investigator, Orianna Bretschger, has been working to understand the microbes and mechanisms associated with MFCs to develop practical applications of the technology.

"With this grant, we can expand and apply what we have learned about fundamental microbial processes toward the development of integrated MFC systems that can provide reliable and cost-effective wastewater treatment," Bretschger said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.